Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc. has been notified of a change in major shareholdings by Pentwater Capital Management LP, with the investment firm now holding a total of 2.524% of the company’s shares. The notification was triggered by an event changing the breakdown of shares outstanding, crossing a notifiable threshold on May 9, 2024, and the company was informed the following day. This shift in share distribution could signal strategic moves by shareholders and may be of interest to investors monitoring the company’s stock.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
